SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001013762-23-003541
Filing Date
2023-10-12
Accepted
2023-10-12 16:17:10
Documents
16
Period of Report
2023-10-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea186616-8k_60degrees.htm   iXBRL 8-K 29089
2 PRESS RELEASE OF 60 DEGREES PHARMACEUTICALS, INC. DATED AS OF OCTOBER 12, 2023 ea186616ex99-1_60degrees.htm EX-99.1 34352
3 GRAPHIC ex99-1_001.jpg GRAPHIC 3832
4 GRAPHIC ex99-1_002.jpg GRAPHIC 21560
  Complete submission text file 0001013762-23-003541.txt   327254

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE sxtp-20231006.xsd EX-101.SCH 3813
6 XBRL DEFINITION FILE sxtp-20231006_def.xml EX-101.DEF 26668
7 XBRL LABEL FILE sxtp-20231006_lab.xml EX-101.LAB 36762
8 XBRL PRESENTATION FILE sxtp-20231006_pre.xml EX-101.PRE 25292
10 EXTRACTED XBRL INSTANCE DOCUMENT ea186616-8k_60degrees_htm.xml XML 5325
Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Filer) CIK: 0001946563 (see all company filings)

IRS No.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41719 | Film No.: 231322915
SIC: 2834 Pharmaceutical Preparations